Target intelligence / Profile preview

Protein cysteine residues (Cys) (Cys)

Target
Cys
Molecular classification
Other
01

Overview

Protein cysteines are amino acid residues characterized by a highly nucleophilic thiol (-SH) side chain, which is essential for various biological processes including enzymatic catalysis, metal ion coordination, and the formation of stabilizing disulfide bonds (Singh et al., 2011, Nature Reviews Drug Discovery). They serve as critical sensors in redox signaling, where the oxidation state of the thiol group can modulate protein function in response to cellular oxidative stress (Go & Jones, 2013, Free Radical Biology and Medicine). In drug discovery, specific cysteine residues are targeted by covalent inhibitors—such as Ibrutinib targeting Cys481 in Bruton's tyrosine kinase—to achieve high potency and prolonged pharmacological effects (Backus et al., 2016, Nature). However, because cysteines are ubiquitous across the proteome, the term "Protein cysteines" refers to a broad chemical class rather than a single therapeutic entity, making global targeting a challenge due to potential off-target reactivity and toxicity (Resnick et al., 2024, Journal of Medicinal Chemistry). Consequently, while individual cysteines within specific proteins are high-value targets, the collective group of protein cysteines is not considered a single drug target.

Other names
Cysteine residuesProtein thiolsCysReactive cysteinesCysteinome
02

Mechanism of action

Covalent modification of the cysteine thiol group via electrophilic warheads, typically through Michael addition or nucleophilic substitution, to irreversibly or reversibly inhibit protein function.

03

Biological functions

CatalysisRedox signalingStructural stabilizationPost-translational modificationMetal ion binding
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionNeurodegenerative disease
05

Safety considerations

Off-target reactivityHapten formationHypersensitivityIdiosyncratic toxicityDepletion of cellular antioxidants
06

Interacting drugs

Ibrutinib

5 more in the full profile.

07

Biomarkers

Cysteine occupancyGlutathione levelsProtein sulfenylation

Beyond the preview

Go deeper on Protein cysteine residues (Cys) (Cys).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein cysteine residues (Cys) (Cys).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call